Craig really lol Alright I’ll bite. NASH alone
Post# of 157631
Alright I’ll bite. NASH alone it’s expected to be a 180 billion dollar market by 2028. Cancer by 2030 is 277 billion dollar market.
If we could treat NASH alone/ approval you are looking at a SP of at a minimum of 50 dollars a share IMO within the next 5 years or less.
So yea if you believe we could pull this off then .30 is cheap. I gave up on timing the stock. I just buy when I can. Risky, sure very risky. You have to take risk sometimes.


CytoDyn Inc (CYDY) Stock Research Links
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf